Paste your Google Webmaster Tools verification code here

Month: February 2019

Home   >   Month: February 2019

RenalytixAI and AKESOgen In Joint Venture Partnership for Expanded Testing Capacity and Pharma Services

RenalytixAI Logo

NEW YORK, Feb. 13, 2019 — RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility and provider of clinical trial precision medicine services located in Atlanta, Georgia. AKESOgen brings a state-of-the-art 14,000 square foot CLIA1
Read More